Avanos Medical (AVNS) Competitors $12.02 -0.11 (-0.87%) As of 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVNS vs. EYE, LMAT, PRCT, LQDA, AORT, ENOV, CNMD, NVCR, CDRE, and KMTSShould you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include National Vision (EYE), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), Liquidia Technologies (LQDA), Artivion (AORT), Enovis (ENOV), CONMED (CNMD), NovoCure (NVCR), Cadre (CDRE), and Kestra Medical Technologies (KMTS). These companies are all part of the "medical equipment" industry. Avanos Medical vs. Its Competitors National Vision LeMaitre Vascular PROCEPT BioRobotics Liquidia Technologies Artivion Enovis CONMED NovoCure Cadre Kestra Medical Technologies National Vision (NASDAQ:EYE) and Avanos Medical (NYSE:AVNS) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Do analysts prefer EYE or AVNS? National Vision presently has a consensus target price of $24.73, indicating a potential downside of 9.81%. Given National Vision's stronger consensus rating and higher possible upside, equities analysts plainly believe National Vision is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has higher earnings and valuation, EYE or AVNS? National Vision has higher revenue and earnings than Avanos Medical. National Vision is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$1.82B1.19-$28.50M-$0.18-152.32Avanos Medical$687.80M0.81-$392.10M-$10.07-1.20 Which has more volatility and risk, EYE or AVNS? National Vision has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Is EYE or AVNS more profitable? National Vision has a net margin of -0.75% compared to Avanos Medical's net margin of -66.89%. Avanos Medical's return on equity of 6.16% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-0.75% 3.56% 1.49% Avanos Medical -66.89%6.16%4.57% Does the media prefer EYE or AVNS? In the previous week, National Vision had 6 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for National Vision and 3 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.14 beat National Vision's score of 0.88 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in EYE or AVNS? 95.2% of Avanos Medical shares are owned by institutional investors. 2.7% of National Vision shares are owned by insiders. Comparatively, 2.6% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryNational Vision beats Avanos Medical on 11 of the 16 factors compared between the two stocks. Get Avanos Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVNS vs. The Competition Export to ExcelMetricAvanos MedicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$559.12M$6.72B$5.74B$21.66BDividend YieldN/A1.21%5.61%3.51%P/E Ratio-1.2026.4276.7430.09Price / Sales0.81194.90552.0060.69Price / Cash1.0022.1425.8118.30Price / Book0.675.0613.644.65Net Income-$392.10M$178.07M$3.29B$1.00B7 Day Performance1.35%2.19%1.89%1.14%1 Month Performance3.09%7.21%4.26%2.93%1 Year Performance-49.18%20.89%80.80%15.27% Avanos Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVNSAvanos Medical1.8383 of 5 stars$12.05-0.7%N/A-49.7%$559.12M$687.80M-1.202,227Positive NewsEYENational Vision2.0706 of 5 stars$26.60-1.2%$24.73-7.0%+151.4%$2.13B$1.82B-147.7813,411LMATLeMaitre Vascular3.2041 of 5 stars$92.29+0.0%$97.60+5.8%+2.6%$2.09B$219.86M44.80490Positive NewsAnalyst ForecastPRCTPROCEPT BioRobotics2.7991 of 5 stars$38.46+2.9%$70.00+82.0%-54.7%$2.08B$224.50M-24.81430Positive NewsLQDALiquidia Technologies3.9503 of 5 stars$22.90-3.7%$32.11+40.2%+130.2%$2.05B$14M-13.4750High Trading VolumeAORTArtivion2.5823 of 5 stars$41.16+1.5%$40.63-1.3%+63.3%$1.91B$388.54M-98.001,600Positive NewsENOVEnovis3.9634 of 5 stars$32.37+0.0%$51.00+57.6%-25.9%$1.85B$2.11B-2.277,367Positive NewsCNMDCONMED4.4032 of 5 stars$50.07+0.1%$59.80+19.4%-33.5%$1.55B$1.31B14.183,900Positive NewsNVCRNovoCure4.3331 of 5 stars$13.09+3.2%$28.79+119.9%-25.0%$1.42B$605.22M-8.391,488CDRECadre2.4771 of 5 stars$34.48+2.1%$31.50-8.6%-9.3%$1.37B$567.56M36.682,284KMTSKestra Medical Technologies0.6544 of 5 stars$25.55+2.4%$27.33+7.0%N/A$1.28B$59.81M0.00300Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies National Vision Competitors LeMaitre Vascular Competitors PROCEPT BioRobotics Competitors Liquidia Technologies Competitors Artivion Competitors Enovis Competitors CONMED Competitors NovoCure Competitors Cadre Competitors Kestra Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AVNS) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVNS Stock Alerts